Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma

Blood. 2002 Jun 1;99(11):4251-2; author reply 4252. doi: 10.1182/blood-2002-02-0624.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Combined Modality Therapy
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Melphalan / therapeutic use*
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / therapy*
  • Neutropenia / prevention & control*
  • Thrombocytopenia / prevention & control*
  • Transplantation, Autologous
  • Whole-Body Irradiation

Substances

  • Melphalan